Calmare Therapeutics (CTTC)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2011 | 12-2010 | 07-2010 | 07-2009 | 07-2008 | |
| Sales | 3,445 | 0 | 2,010 | 348 | 1,193 |
| Cost of Goods | 3,069 | N/A | 2,577 | 2,025 | 3,256 |
| Gross Profit | 376 | N/A | -567 | -1,677 | -2,063 |
| Operating Expenses | 3,989 | 0 | 2,711 | 2,225 | 3,861 |
| Operating Income | -3,544 | N/A | -2,701 | -3,877 | -5,668 |
| Interest Expense | 36 | 0 | 8 | 3 | 0 |
| Other Income | -16 | 0 | 0 | 400 | -299 |
| Pre-tax Income | -3,596 | 0 | -2,709 | -3,480 | -5,967 |
| Net Income Continuous | -3,596 | N/A | -2,709 | -3,480 | -5,967 |
| Net Income | $-3,596 | $N/A | $-2,709 | $-3,480 | $-5,967 |
| EPS Basic Total Ops | -0.26 | N/A | -0.25 | -0.40 | -0.73 |
| EPS Basic Continuous Ops | -0.25 | N/A | -0.25 | -0.40 | -0.73 |
| EPS Diluted Total Ops | -0.26 | N/A | -0.25 | -0.40 | -0.73 |
| EPS Diluted Continuous Ops | -0.25 | N/A | -0.25 | -0.40 | -0.73 |
| EPS Diluted Before Non-Recurring Items | -0.26 | N/A | N/A | N/A | N/A |
| EBITDA(a) | $-3,524 | $N/A | $-2,646 | $-3,816 | $-5,596 |